Watchlist Price Alert

Eterna Therapeutics Inc. (ERNA)

NASDAQ: ERNA · Real-Time Price · USD

2.29

-0.08 (-3.38%)

At close: Jun 13, 2025, 3:59 PM

2.35

2.84%

After-hours: Jun 13, 2025, 05:05 PM EDT

Eterna Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	1.92M	1.73M	4.26M	2.59M	5.12M	7.58M	4.55M	1.84M	5.4M	11.45M	13.25M	19.41M	23.5M	16.98M	24.38M	50.16M	8.41M	1.63M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	4.09M	4.09M	4.09M	4.09M	4.09M	8K	59K	68K	89K	385K	1M	1M	n/a	n/a	n/a
Other Long-Term Assets	118K	118K	120K	120K	120K	120K	8.14M	5.47M	5.34M	5.23M	819K	477K	421K	522K	519.47K	514.88K	488.53K	453K
Receivables	156K	437K	187K	228K	351K	425K	1.78M	984K	647K	951K	926K	694K	835K	684K	23.3K	23.3K	53.41K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-951K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	137K	186K	279K	769K	697K	1.6M	704K	1.07M	471K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	2.21M	2.35M	4.73M	3.58M	6.16M	9.6M	7.03M	3.89M	6.51M	13.68M	15.85M	21.93M	25.14M	18.77M	25.76M	51.94M	8.71M	1.73M
Property-Plant & Equipment	686K	755K	824K	36.64M	37.23M	33.27M	35.03M	35.55M	1.2M	1.27M	2.14M	2.37M	1.4M	3.24M	3.21M	3.35M	2.59M	2.69M
Goodwill & Intangibles	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	8.03M	8.9M	8.9M	8.9M	8.9M	8.03M
Total Long-Term Assets	2.85M	2.92M	2.99M	42.9M	43.49M	39.53M	45.22M	43.06M	8.59M	8.6M	5.07M	4.98M	10.24M	13.66M	13.64M	12.77M	11.98M	11.17M
Total Assets	5.06M	5.27M	7.72M	46.49M	49.66M	49.13M	52.25M	46.95M	15.11M	22.28M	20.93M	26.9M	35.38M	32.43M	39.39M	64.71M	20.7M	12.91M
Account Payables	1.27M	1.72M	2.19M	2.19M	2.06M	1.07M	1.46M	2.67M	1.46M	1.62M	1.15M	1.48M	1.11M	1.75M	996.26K	3.68M	1.81M	1.27M
Deferred Revenue	n/a	n/a	n/a	189K	189K	190K	349K	250K	250K	n/a	n/a	n/a	n/a	n/a	2.13M	1.92M	n/a	n/a
Short-Term Debt	2.46M	n/a	201K	4.27M	2.87M	2.22M	1.64M	173K	168K	1.75M	439K	390K	149K	n/a	410K	719.9K	642.24K	526K
Other Current Liabilities	6.69M	12K	7.43M	-1.79M	-439K	773K	4.9M	3.81M	3.4M	2.92M	3.91M	3.25M	533K	840K	2.16M	2.52M	572.08K	294K
Total Current Liabilities	10.44M	2.94M	9.95M	9.6M	7.77M	6.57M	9.63M	7.17M	5.41M	7.65M	7.47M	7.12M	3.68M	3.68M	4.56M	7.68M	3.9M	3.13M
Long-Term Debt	419K	n/a	32.04M	8.89M	8.01M	6.77M	3.45M	331K	1.61M	2.09M	n/a	n/a	n/a	n/a	n/a	n/a	77.67K	194K
Other Long-Term Liabilities	152K	153K	10.59M	175K	377K	307K	360K	194K	-378K	-462K	2.32M	2.57M	13.36M	19.95M	19.38M	19.31M	19.31M	23K
Total Long-Term Liabilities	571K	630K	43.16M	45.41M	45.3M	40.33M	39.06M	35.92M	2.32M	2.52M	4.65M	5M	14.38M	22.25M	21.79M	21.84M	21.22M	2.12M
Total Liabilities	11.01M	3.57M	53.11M	55.01M	53.07M	46.9M	48.69M	43.09M	7.73M	10.17M	12.11M	12.12M	18.07M	25.93M	26.35M	29.53M	25.12M	5.25M
Total Debt	2.88M	684K	33.55M	49.2M	47.45M	41.84M	41.24M	37.22M	3.53M	4.14M	2.76M	2.82M	1.17M	2.72M	3.23M	3.63M	2.83M	2.9M
Common Stock	262K	257K	27K	27K	27K	27K	27K	27K	26K	26K	15K	287K	287K	260K	260.22K	223.54K	207.53K	25.8M
Retained Earnings	-239.74M	-231.54M	-225.77M	-199.16M	-193.63M	-186.98M	-180.82M	-175.23M	-170.71M	-165.3M	-160.8M	-153.48M	-150.08M	-159.7M	-151.23M	-65.18M	-55.08M	-18.14M
Comprehensive Income	n/a	n/a	n/a	-1K	-1K	-27K	-1K	-1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-5.95M	1.7M	-45.39M	-8.53M	-3.41M	2.23M	3.56M	3.87M	7.38M	12.11M	8.81M	14.78M	17.31M	6.5M	13.04M	35.18M	-4.42M	7.66M
Total Investments	n/a	n/a	n/a	4.09M	4.09M	4.09M	4.09M	4.09M	8K	59K	68K	89K	385K	1M	1M	n/a	n/a	n/a